Wednesday 28 June
08:30 Registration and breakfast
09:20 Chair’s opening remarks

Max Bryan, head of science & technology, Bidwells

Tim Burke, deputy editor, EG
09:30 Opening keynote: Perspectives of a Supercluster

Sir Jonathan Symonds CBE, life sciences champion and chair, GSK
09:50 Accelerating innovation as a key driver of our economic future
  • Future technologies – the need for long-term strategic plans and investment
  • The role of universities – how do we continue to support spin-outs?
  • How do we make the UK more attractive for R&D and the best scientific talent
Baroness Nicola Blackwood, chair, Genomics England

Sir Peter Knight, senior research investigator, Imperial College London, National Quantum Strategy

Steve Rees OBE, vice president of discovery biology, AstraZeneca

Lord David Willetts, president, Resolution Foundation, chair, UK Space Agency

Chair: Dr Barbara Ghinelli, director, Innovation Clusters and Harwell Campus, UKRI STFC

10:35 Keynote: Cementing the UK as a Scientific Superpower

The Rt Hon Chloe Smith MP, secretary of state for science, innovation and technology
10:55 Networking and refreshment break
11:20 The power of clusters: Unleashing scientific convergence

Sue Foxley, research director, Bidwells
11:30 Creating a world-class supercluster through the convergence of science and technology
  • How can we enable the convergence of science and technology within the Arc?
  • Nurturing vibrant clusters to encourage collaboration and knowledge-sharing
  • How do we make the UK more attractive for R&D and the best scientific talent
Katherine Morgan, head of high growth & entrepreneurs, Barclays

Sharon Parker-Lines, deputy managing director and operations director, Astroscale UK

Kristin-Anne Rutter, executive director, Cambridge Biodmedical Campus

Isobel Stephen, executive director – strategy, performance and engagement, UKRI

Chair: Sarah Haywood, managing director, Advanced Oxford

12:15 Evolution of real estate for a new era of science and technology
  • Defining the next generation of world-leading science, manufacturing and laboratory buildings
  • What is needed to build Green Labs
  • Building science and technology real estate that benefits the community
Emma Cariaga, joint head of Canada Water & head of residential, British Land

Jenny Gardner, director of development, ARC

Artem Korolev, founder & chief executive Mission Street

Orestis Tzortzoglou, vice-president of development, BioMed Realty

Chair: Richard Todd, head of Oxford, Bidwells

13:00 Lunch break
13:45 Revaluation of science and technology: The investor outlook
  • Emerging opportunities and investment outlook in science and technology
  • Funding science and technology in the UK vs other markets
  • How do we fast-track the scaling of UK innovation?
Dr Glenn Crocker, executive director, Pioneer Group

Hitesh Thakrar, partner, Syncona Investment Management

Rebecca Todd, investment director, Longwall Venture Partners

Chair: Tim Burke, deputy editor, EG
14:30 In conversation with: East West rail as a catalyst for scientific growth

Neil Sachdev MBE, chair, East West Railway Company

Tim Burke, deputy editor, EG
14:50 Networking and refreshment break
15:20 Keynote: Unleashing Innovation for a Net Zero Future

The Rt Hon Grant Shapps MP, secretary of state for energy security and net zero
15:40 Unleashing the Oxford-Cambridge Corridor as an engine for growth
  • How does the OxCam Arc maximise return on investment?
  • Unlocking the Arc’s potential through infrastructure
  • The Arc’s global brand on the international stage
Richard Hutchins, managing director, Oxford to Cambridge Partnership

Neelam Patel, chief executive, Med City

Sir John Peace, chair, Midlands Engine

Dr Andy Williams, chair, Oxford-Cambridge Supercluster board

Chair: Professor Andy Neely OBE, senior pro-vice-chancellor for enterprise and business, University of Cambridge
16:25 Breaking boundaries: Global science and tech giants investing in the UK

Karen Frieze, head of healthcare, Life Sciences & Bioeconomy, Investment Services Team, Department for Business and Trade

Greg Pada, vice-president, head of engineering business, AVEVA

Sheelpa Patel, chief marketing officer, Oxa

Professor Wolf Reik, director, Altos Labs, Cambridge Institute of Science

Professor Matthew Snape, vice-president, paediatric and maternal vaccine clinical development, Moderna

Chair: Tim Burke, deputy editor, EG
17:15 Chair’s closing remarks